Major Victory For Genmab As Epkinly Receives FDA Approval For Type Of Pretreated Blood Cancer

benzinga.com/news/fda/25/11/48931917/major-victory-for-genmab-as-epkinly-receives-fda-approval-for-type-of-pretreated-blood-cancer

The U.S. Food and Drug Administration approved Genmab A/S (NASDAQ:GMAB) Epkinly (epcoritamab-bysp) on Tuesday with lenalidomide and rituximab for relapsed or refractory follicular lymphoma (FL).
The FDA also granted traditional approval to epcoritamab-bysp as monotherapy for relapsed or…

This story appeared on benzinga.com, 2025-11-18 17:58:26.
The Entire Business World on a Single Page. Free to Use →